EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Psychological Distress and Quality of Life in Families With a Germline CDKN2A Pathogenic Variant

A M Onnekink iD, D C F Klatte iD, J E van Hooft, S H van den Berg, S M S van der Zwaan, R van Doorn, S C H Hinnen, T P Potjer, E M A Bleiker, M E van Leerdam

Molecular Genetics & Genomic Medicine · 2025

DOI: 10.1002/mgg3.70045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2025. Verfasst von A M Onnekink und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Quality of Life, Germ-Line Mutation, Psychological Distress, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Individuals with a germline CDKN2A pathogenic variant (PV) have an increased lifetime risk of melanoma and pancreatic cancer. It is unknown whether the CDKN2A PV impacts quality of life (QoL). Therefore we aimed to assess QoL and psychological distress in families affected by the PV.

Methods

This cross‐sectional study included confirmed carriers and those with a 50% likelihood of carrying the PV (at‐risk carriers) under cancer surveillance who were invited to complete a one‐time questionnaire. Both confirmed and at‐risk carriers are offered skin surveillance, whereas only confirmed carriers aged 40 years or older can participate in pancreatic surveillance.

Results

In total, 59/247 (24%) individuals under skin surveillance only (skin surveillance group) and 188/290 (65%) individuals under both skin and pancreatic cancer surveillance (pancreatic surveillance group) responded. In both surveillance groups, health‐related QoL and general distress levels were within the general population norms. However, more than 40% of all study participants reported melanoma‐related distress. Pancreatic cancer‐related distress was experienced by 45% of the pancreatic surveillance group. Determinants of cancer‐related distress were a first‐degree relative with melanoma or pancreatic cancer, increased cancer risk perception, and poor general health perception. Over 80% of the participants felt that the benefits of cancer surveillance outweigh the disadvantages.

Conclusion

In conclusion, confirmed and at‐risk carriers of the CDKN2A PV under cancer surveillance experienced similar levels of QoL and general distress compared to the general population. However, cancer‐related worry was substantial in this population. These findings can help identify individuals who may benefit from psychological support.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeGerm-Line MutationPsychological DistressCyclin-Dependent Kinase Inhibitor p16Pancreatic NeoplasmsMelanomaSkin NeoplasmsHumansMaleMiddle AgedFemaleAdultAged

Stichwörter der Autor:innen

CDKN2Acancer surveillancecancer worrygenomic medicinehereditary cancer syndromehereditary melanomahereditary pancreatic cancermolecular geneticspsychological distressquality of life

Substanzen

Cyclin-Dependent Kinase Inhibitor p16CDKN2A protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA.
  • Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Psycho-Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Medical Psychology, Spaarne Gasthuis, Haarlem, the Netherlands.
  • Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.

ORCID-Profile: A M Onnekink, D C F Klatte

Zitieren

APA

Onnekink, A. M., Klatte, D. C. F., van Hooft, J. E., van den Berg, S. H., van der Zwaan, S. M. S., van Doorn, R., Hinnen, S. C. H., Potjer, T. P., Bleiker, E. M. A., & van Leerdam, M. E. (2025). Psychological Distress and Quality of Life in Families With a Germline CDKN2A Pathogenic Variant. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70045

Vancouver

Onnekink AM, Klatte DCF, van Hooft JE, van den Berg SH, van der Zwaan SMS, van Doorn R, et al. Psychological Distress and Quality of Life in Families With a Germline CDKN2A Pathogenic Variant. Molecular Genetics & Genomic Medicine. 2025. doi:10.1002/mgg3.70045

BibTeX
@article{Onnekink2025,
  author = {Onnekink, A M and Klatte, D C F and van Hooft, J E and van den Berg, S H and van der Zwaan, S M S and van Doorn, R and Hinnen, S C H and Potjer, T P and Bleiker, E M A and van Leerdam, M E},
  title = {Psychological Distress and Quality of Life in Families With a Germline CDKN2A Pathogenic Variant},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2025},
  doi = {10.1002/mgg3.70045}
}
Kostenlos starten →